Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: respiratory infections therapeutics - Ena Respiratory

Next Previous
Drug Profile

Research programme: respiratory infections therapeutics - Ena Respiratory

Alternative Names: INNA-X molecules - Ena Respiratory; INNA-X series

Latest Information Update: 28 Jun 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Ena Respiratory
  • Class Antiasthmatics
  • Mechanism of Action Toll-like receptor 2 agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Respiratory tract infections

Most Recent Events

  • 28 Jun 2023 No recent reports of development identified for preclinical development in Respiratory-tract-infections in Australia (Topical)
  • 17 Dec 2020 Interim pharmacodynamics data from a preclinical trial in Respiratory tract infections released by Ena Respiratory
  • 29 May 2019 Ena Respiratory has allowed patents in USA and Europe, with several PCT applications, covering the INNA-X series of molecules

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top